These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 31026511)

  • 1. Oxysterols and the NeuroVascular Unit (NVU): A far true love with bright and dark sides.
    Saint-Pol J; Gosselet F
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105368. PubMed ID: 31026511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol as a modifying agent of the neurovascular unit structure and function under physiological and pathological conditions.
    Czuba E; Steliga A; Lietzau G; Kowiański P
    Metab Brain Dis; 2017 Aug; 32(4):935-948. PubMed ID: 28432486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.
    Gosselet F; Saint-Pol J; Fenart L
    Biochem Biophys Res Commun; 2014 Apr; 446(3):687-91. PubMed ID: 24275140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterol derivatives of cholesterol in neurodegenerative disorders.
    Jeitner TM; Voloshyna I; Reiss AB
    Curr Med Chem; 2011; 18(10):1515-25. PubMed ID: 21428891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.
    Huang W; Xia Q; Zheng F; Zhao X; Ge F; Xiao J; Liu Z; Shen Y; Ye K; Wang D; Li Y
    J Alzheimers Dis; 2023; 94(s1):S335-S354. PubMed ID: 36683511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease.
    Banerjee S; Banerjee S
    Methods Mol Biol; 2024; 2761():355-372. PubMed ID: 38427250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.
    Saint-Pol J; Candela P; Boucau MC; Fenart L; Gosselet F
    Brain Res; 2013 Jun; 1517():1-15. PubMed ID: 23603412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.
    Salmina AB; Kharitonova EV; Gorina YV; Teplyashina EA; Malinovskaya NA; Khilazheva ED; Mosyagina AI; Morgun AV; Shuvaev AN; Salmin VV; Lopatina OL; Komleva YK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.
    Huang Z; Wong LW; Su Y; Huang X; Wang N; Chen H; Yi C
    Front Neuroendocrinol; 2020 Oct; 59():100857. PubMed ID: 32781194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxysterols and Alzheimer's disease.
    Björkhem I; Heverin M; Leoni V; Meaney S; Diczfalusy U
    Acta Neurol Scand Suppl; 2006; 185():43-9. PubMed ID: 16866910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstituting neurovascular unit with primary neural stem cells and brain microvascular endothelial cells in three-dimensional matrix.
    Wang H; Yang H; Shi Y; Xiao Y; Yin Y; Jiang B; Ren H; Chen W; Xue Q; Xu X
    Brain Pathol; 2021 Sep; 31(5):e12940. PubMed ID: 33576166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Targeting of the Neurovascular Unit: Challenges and Advancements.
    Naranjo O; Osborne O; Torices S; Toborek M
    Cell Mol Neurobiol; 2022 Oct; 42(7):2131-2146. PubMed ID: 34086179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
    Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
    J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain.
    Björkhem I
    J Intern Med; 2006 Dec; 260(6):493-508. PubMed ID: 17116000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the blood-brain barrier in Alzheimer's disease].
    Gosselet F; Candela P; Cecchelli R; Fenart L
    Med Sci (Paris); 2011 Nov; 27(11):987-92. PubMed ID: 22130026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation.
    Testa G; Staurenghi E; Zerbinati C; Gargiulo S; Iuliano L; Giaccone G; Fantò F; Poli G; Leonarduzzi G; Gamba P
    Redox Biol; 2016 Dec; 10():24-33. PubMed ID: 27687218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer's disease pathogenesis.
    Giorgi FS; Galgani A; Puglisi-Allegra S; Limanaqi F; Busceti CL; Fornai F
    J Neurosci Res; 2020 Dec; 98(12):2406-2434. PubMed ID: 32875628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-brain barrier in Alzheimer's disease.
    Zenaro E; Piacentino G; Constantin G
    Neurobiol Dis; 2017 Nov; 107():41-56. PubMed ID: 27425887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineered neurovascular unit for modeling neuroinflammation.
    Seo S; Choi CH; Yi KS; Kim SU; Lee K; Choi N; Lee HJ; Cha SH; Kim HN
    Biofabrication; 2021 May; 13(3):. PubMed ID: 33849004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.